The U.S. Food and Drug Administration is refusing to review Moderna’s flu vaccine for approval, a potentially huge setback for the Cambridge drugmaker on its path to better financial footing.

The three-story building will feature new exhibits, flexible classrooms, and interactive engagement spaces.

The public release improves audio, speech, debugging, and developer experience. Additionally, a more cost-effective mini ...